These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17584824)

  • 1. Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer.
    Kawashima M; Hayashi R; Tahara M; Yamazaki M; Miyazaki M; Arahira S; Ogino T
    Jpn J Clin Oncol; 2007 May; 37(5):345-52. PubMed ID: 17584824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
    Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH; Kal HB; Hordijk GJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical radiobiology of stage T2-T3 bladder cancer.
    Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
    Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
    Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx.
    Nakamura K; Shioyama Y; Sasaki T; Ohga S; Saku M; Urashima Y; Yoshitake T; Nakashima T; Kuratomi Y; Komune S; Terashima H; Honda H
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):680-3. PubMed ID: 15936545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy.
    Nakamura K; Shioyama Y; Kawashima M; Saito Y; Nakamura N; Nakata K; Hareyama M; Takada T; Karasawa K; Watanabe T; Yorozu A; Tachibana H; Suzuki G; Hayabuchi N; Toba T; Yamada S
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1045-50. PubMed ID: 16682142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective trial of chemotherapy-enhanced accelerated radiotherapy for larynx preservation in patients with intermediate-volume hypopharyngeal cancer.
    Kawashima M; Hayashi R; Tahara M; Arahira S; Miyazaki M; Sakuraba M; Zenda S; Ogino T
    Head Neck; 2012 Oct; 34(10):1363-8. PubMed ID: 22076936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
    Semrau R; Mueller RP; Stuetzer H; Staar S; Schroeder U; Guntinas-Lichius O; Kocher M; Eich HT; Dietz A; Flentje M; Rudat V; Volling P; Schroeder M; Eckel HE
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1308-16. PubMed ID: 16464538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
    Ozer E; Grecula JC; Agrawal A; Rhoades CA; Schuller DE
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):385-9. PubMed ID: 16618907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMRT in hypopharyngeal tumors.
    Studer G; Lütolf UM; Davis JB; Glanzmann C
    Strahlenther Onkol; 2006 Jun; 182(6):331-5. PubMed ID: 16703288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
    Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
    Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.